12 2 STA T . 2 495PUBLIC LA W 11 0– 2 7 5 —J UL Y 15 , 200 8Subti t leC—Prov i s io n s R el a tin g to Part B P ARTI —P HYSIC IA N S ’ S E R V ICES Se c.13 1.P hy sician p ay m ent , e f ficiency, an dq uality improvements. Sec. 13 2 . Incentives for electronic prescribing. Sec. 133. Ex panding access to primary care services. Sec. 13 4 . Extension of floor on M edicare w or k geographic ad j ustment under the Medicare physician fee schedule. Sec. 13 5 . Imaging provisions. Sec. 13 6 . Extension of treatment of certain physician pathology services under Medicare. Sec. 13 7 . A ccommodation of physicians ordered to active duty in the Armed Serv - ices. Sec. 13 8 . Adjustment for Medicare mental health services. Sec. 13 9 . Improvements for Medicare anesthesia teaching programs. PART II— O THER PAY M ENT AN D C O VERA G EIM P ROVEMENTS Sec. 141. Extension of exceptions process for Medicare therapy caps. Sec. 142. Extension of payment rule for brachytherapy and therapeutic radio- pharmaceuticals. Sec. 143. Speech-language pathology services. Sec. 144. Payment and coverage improvements for patients with chronic obstructive pulmonary disease and other conditions. Sec. 145. Clinical laboratory tests. Sec. 146. Improved access to ambulance services. Sec. 147. Extension and expansion of the Medicare hold harmless provision under the prospective payment system for hospital outpatient department (H OP D) services for certain hospitals. Sec. 148. Clarification of payment for clinical laboratory tests furnished by critical access hospitals. Sec. 149. Adding certain entities as originating sites for payment of telehealth serv- ices. Sec. 15 0 . MedPAC study and report on improving chronic care demonstration pro- grams. Sec. 151. Increase of FQ HC payment limits. Sec. 152. K idney disease education and awareness provisions. Sec. 153. Renal dialysis provisions. Sec. 154. Delay in and reform of Medicare DMEPOS competitive acquisition pro- gram. Subtitle D—Provisions Relating to Part C Sec. 161. Phase-out of indirect medical education (IME). Sec. 162. Revisions to requirements for Medicare Advantage private fee-for-service plans. Sec. 163. Revisions to quality improvement programs. Sec. 164. Revisions relating to speciali z ed Medicare Advantage plans for special needs individuals. Sec. 165. L imitation on out-of-pocket costs for dual eligibles and qualified medicare beneficiaries enrolled in a specialized Medicare Advantage plan for spe- cial needs individuals. Sec. 166. Adjustment to the Medicare Advantage stabilization fund. Sec. 167. Access to Medicare reasonable cost contract plans. Sec. 168. MedPAC study and report on quality measures. Sec. 169. MedPAC study and report on Medicare Advantage payments. Subtitle E—Provisions Relating to Part D PART I—IMPROVING PHARMACY ACCESS Sec. 171. Prompt payment by prescription drug plans and MA – PD plans under part D. Sec. 172. Submission of claims by pharmacies located in or contracting with long- term care facilities. Sec. 173. Regular update of prescription drug pricing standard. PART II—OTHER PROVISIONS Sec. 175. Inclusion of barbiturates and benzodiazepines as covered part D drugs. Sec. 176. Formulary requirements with respect to certain categories or classes of drugs. Subtitle F—Other Provisions Sec. 181. U se of part D data.
�
